{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:31:31Z","timestamp":1779906691402,"version":"3.53.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2474-15-450","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T07:14:41Z","timestamp":1434611681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients"],"prefix":"10.1186","volume":"15","author":[{"given":"Ilya A","family":"Lipkovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest H","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Van Wambeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Deberdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Sagman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,23]]},"reference":[{"issue":"2","key":"2393_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990, 33 (2): 160-172. 10.1002\/art.1780330203.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2393_CR2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s11916-001-0021-2","volume":"5","author":"KP White","year":"2001","unstructured":"White KP, Harth M: Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep. 2001, 5 (4): 320-329. 10.1007\/s11916-001-0021-2.","journal-title":"Curr Pain Headache Rep"},{"issue":"5","key":"2393_CR3","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB: The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010, 62 (5): 600-610. 10.1002\/acr.20140.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"2393_CR4","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/art.20485","volume":"50","author":"LM Arnold","year":"2004","unstructured":"Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ: A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004, 50 (9): 2974-2984. 10.1002\/art.20485.","journal-title":"Arthritis Rheum"},{"issue":"1\u20133","key":"2393_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","volume":"119","author":"LM Arnold","year":"2005","unstructured":"Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF: A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005, 119 (1\u20133): 5-15.","journal-title":"Pain"},{"key":"2393_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.ne.07.030184.001521","volume":"7","author":"AI Basbaum","year":"1984","unstructured":"Basbaum AI, Fields HL: Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984, 7: 309-338. 10.1146\/annurev.ne.07.030184.001521.","journal-title":"Annu Rev Neurosci"},{"issue":"1\u20132","key":"2393_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0006-8993(93)90210-E","volume":"616","author":"FM Clark","year":"1993","unstructured":"Clark FM, Proudfit HK: The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception. Brain Res. 1993, 616 (1\u20132): 200-210.","journal-title":"Brain Res"},{"issue":"3","key":"2393_CR8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1017\/S0140525X97251484","volume":"20","author":"TJ Coderre","year":"1997","unstructured":"Coderre TJ, Katz J: Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain. Behav Brain Sci. 1997, 20 (3): 404-419.","journal-title":"Behav Brain Sci"},{"issue":"1","key":"2393_CR9","first-page":"104","volume":"19","author":"IJ Russell","year":"1992","unstructured":"Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA: Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia\/fibrositis syndrome. J Rheumatol. 1992, 19 (1): 104-109.","journal-title":"J Rheumatol"},{"issue":"2","key":"2393_CR10","first-page":"90","volume":"2","author":"R Staud","year":"2006","unstructured":"Staud R, Rodriguez ME: Mechanisms of disease: pain in fibromyalgia syndrome. Nature Clinical Practice. Rheumatology. 2006, 2 (2): 90-98.","journal-title":"Rheumatology"},{"issue":"6","key":"2393_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.semarthrit.2006.12.009","volume":"36","author":"MB Yunus","year":"2007","unstructured":"Yunus MB: Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum. 2007, 36 (6): 339-356. 10.1016\/j.semarthrit.2006.12.009.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"2393_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4088\/JCP.v63n0407","volume":"63","author":"MJ Detke","year":"2002","unstructured":"Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA: Duloxetine, 60\u00a0mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry. 2002, 63 (4): 308-315. 10.4088\/JCP.v63n0407.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"2393_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0022-3956(02)00060-2","volume":"36","author":"MJ Detke","year":"2002","unstructured":"Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA: Duloxetine 60\u00a0mg once daily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res. 2002, 36 (6): 383-390. 10.1016\/S0022-3956(02)00060-2.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"2393_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4088\/PCC.v09n0203","volume":"9","author":"H Koponen","year":"2007","unstructured":"Koponen H, Allgulander C, Erickson J, Dunayevich E, Pritchett Y, Detke MJ, Ball SG, Russell JM: Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians. Prim Care Companion J Clin Psychiatry. 2007, 9 (2): 100-107. 10.4088\/PCC.v09n0203.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"Suppl 2","key":"2393_CR15","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1111\/j.1526-4637.2006.00178.x","volume":"8","author":"LM Arnold","year":"2007","unstructured":"Arnold LM: Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med. 2007, 8 (Suppl 2): S63-S74.","journal-title":"Pain Med"},{"issue":"3","key":"2393_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","volume":"136","author":"IJ Russell","year":"2008","unstructured":"Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM: Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008, 136 (3): 432-444. 10.1016\/j.pain.2008.02.024.","journal-title":"Pain"},{"issue":"5","key":"2393_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","volume":"6","author":"J Raskin","year":"2005","unstructured":"Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF: A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005, 6 (5): 346-356. 10.1111\/j.1526-4637.2005.00061.x.","journal-title":"Pain Med"},{"issue":"8","key":"2393_CR18","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1212\/01.wnl.0000240225.04000.1a","volume":"67","author":"JF Wernicke","year":"2006","unstructured":"Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, Raskin J: A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology. 2006, 67 (8): 1411-1420. 10.1212\/01.wnl.0000240225.04000.1a.","journal-title":"Neurology"},{"key":"2393_CR19","volume-title":"Duloxetine 60\u2013120 mg Versus Placebo in the Treatment of Fibromyalgia Syndrome [Poster]","author":"AS Chappell","year":"2007","unstructured":"Chappell AS, Bradley LA, Wiltse C, D\u2019Souza DN, Sp\u00e4th M: Duloxetine 60\u2013120 mg Versus Placebo in the Treatment of Fibromyalgia Syndrome [Poster]. 2007, Boston, MA, USA: ACR"},{"key":"2393_CR20","volume-title":"Safety and Tolerability of Duloxetine in the Treatment of Patients With Fibromyalgia: Analysis of 5 Studies [Poster]","author":"E Choy","year":"2008","unstructured":"Choy E, Mease P, Kajdasz D, Wohlreich M, Walker D, Chappell A: Safety and Tolerability of Duloxetine in the Treatment of Patients With Fibromyalgia: Analysis of 5 Studies [Poster]. 2008, Tampa, FL, USA: Presented at the American Pain Society"},{"issue":"6","key":"2393_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.semarthrit.2008.11.001","volume":"39","author":"PJ Mease","year":"2010","unstructured":"Mease PJ, Russell IJ, Kajdasz DK, Wiltse CG, Detke MJ, Wohlreich MM, Walker DJ, Chappell AS: Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum. 2010, 39 (6): 454-464. 10.1016\/j.semarthrit.2008.11.001.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"2393_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/art.24163","volume":"61","author":"HD Wilson","year":"2009","unstructured":"Wilson HD, Robinson JP, Turk DC: Toward the identification of symptom patterns in people with fibromyalgia. Arthritis Rheum. 2009, 61 (4): 527-534. 10.1002\/art.24163.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2393_CR23","first-page":"728","volume":"18","author":"CS Burckhardt","year":"1991","unstructured":"Burckhardt CS, Clark SR, Bennett RM: The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991, 18 (5): 728-733.","journal-title":"J Rheumatol"},{"issue":"2","key":"2393_CR24","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM: Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994, 23 (2): 129-138.","journal-title":"Ann Acad Med Singapore"},{"key":"2393_CR25","volume-title":"SF-36 Health Survey Manual and Interpretation Guide","author":"JE Ware","year":"1993","unstructured":"Ware JE, Snow KK, Kosinski M, Gandeck B: SF-36 Health Survey Manual and Interpretation Guide. 1993, Boston (MA): The Health Institute, New England Medical Center"},{"key":"2393_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry. 1961, 4: 561-571. 10.1001\/archpsyc.1961.01710120031004.","journal-title":"Arch Gen Psychiatry"},{"key":"2393_CR27","volume-title":"ECDEU Assessment Manual for Psychopharmacology, Revised","author":"W Guy","year":"1976","unstructured":"Guy W: ECDEU Assessment Manual for Psychopharmacology, Revised. 1976, Rockville (MD): US Department of Health, Education, and Welfare Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs"},{"key":"2393_CR28","volume-title":"The Anxiety Disease","author":"DV Sheehan","year":"1983","unstructured":"Sheehan DV: The Anxiety Disease. 1983, New York, NY: Charles Scribner and Sons"},{"issue":"5","key":"2393_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1023\/A:1012552211996","volume":"10","author":"C Taft","year":"2001","unstructured":"Taft C, Karlsson J, Sullivan M: Do SF-36 summary component scores accurately summarize subscale scores?. Qual Life Res. 2001, 10 (5): 395-404. 10.1023\/A:1012552211996.","journal-title":"Qual Life Res"},{"key":"2393_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960, 23: 56-62. 10.1136\/jnnp.23.1.56.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2393_CR31","volume-title":"Cluster Analysis","author":"BS Everitt","year":"1993","unstructured":"Everitt BS: Cluster Analysis. 1993, London: Edward Arnold, 3","edition":"3"},{"key":"2393_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.18637\/jss.v007.i05","volume":"7","author":"IA Lipkovich","year":"2002","unstructured":"Lipkovich IA, Smith EP: Biplot and SVD macros for EXCEL. J Stat Soft. 2002, 7: 5-","journal-title":"J Stat Soft"},{"key":"2393_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF01908075","volume":"2","author":"L Hubert","year":"1985","unstructured":"Hubert L, Arabie P: Comparing partitions. J Classif. 1985, 2: 193-218. 10.1007\/BF01908075.","journal-title":"J Classif"},{"key":"2393_CR34","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1198\/016214503000000666","volume":"98","author":"CA Sugar","year":"2003","unstructured":"Sugar CA, James GM: Finding the number of clusters in a dataset: An information-theoretic approach. J Am Stat Assoc. 2003, 98: 750-763. 10.1198\/016214503000000666.","journal-title":"J Am Stat Assoc"},{"key":"2393_CR35","volume-title":"Classification and Regression Trees","author":"L Breiman","year":"1984","unstructured":"Breiman L, Friedman JH, Olshen RA, Stone CJ: Classification and Regression Trees. 1984, Wadsworth, Belmont: Chapman and Hall\/CRC"},{"issue":"4","key":"2393_CR36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/ard.2007.071522","volume":"67","author":"SF Carville","year":"2008","unstructured":"Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, Da Silva JA, Danneskiold-Sams\u00f8e B, Dincer F, Henriksson C, Henriksson KG, Kosek E, Longley K, McCarthy GM, Perrot S, Puszczewicz M, Sarzi-Puttini P, Silman A, Sp\u00e4th M, Choy EH, EULAR: EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008, 67 (4): 536-541.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2393_CR37","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1002\/art.11272","volume":"48","author":"T Giesecke","year":"2003","unstructured":"Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, Gracely RH, Clauw DJ: Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003, 48 (10): 2916-2922. 10.1002\/art.11272.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2393_CR38","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00296-008-0722-5","volume":"29","author":"JB De Souza","year":"2009","unstructured":"De Souza JB, Goffaux P, Julien N, Potvin S, Charest J, Marchand S: Fibromyalgia subgroups: profiling distinct subgroups using the fibromyalgia impact questionnaire. A preliminary study. Rheumatol Int. 2009, 29 (5): 509-515. 10.1007\/s00296-008-0722-5.","journal-title":"Rheumatol Int"},{"issue":"2","key":"2393_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/YIC.0b013e328341bb5f","volume":"26","author":"DV Sheehan","year":"2011","unstructured":"Sheehan DV, Harnett-Sheehan K, Spann ME, Thompson HF, Prakash A: Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale. Int Clin Psychopharmacol. 2011, 26 (2): 75-83. 10.1097\/YIC.0b013e328341bb5f.","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"2393_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1742-1241.2010.02546.x","volume":"65","author":"D Sagman","year":"2011","unstructured":"Sagman D, McIntosh D, Lee MS, Li H, Ruschel S, Hussain N, Granger RE, Lee AC, Raskin J: Attributes of response in depressed patients switched to treatment with duloxetine. Int J Clin Pract. 2011, 65 (1): 73-81. 10.1111\/j.1742-1241.2010.02546.x.","journal-title":"Int J Clin Pract"},{"issue":"3","key":"2393_CR41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hup.1199","volume":"26","author":"DV Sheehan","year":"2011","unstructured":"Sheehan DV, Chokka PR, Granger RE, Walton RJ, Raskin J, Sagman D: Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetine. Hum Psychopharmacol. 2011, 26 (3): 242-251.","journal-title":"Hum Psychopharmacol"},{"key":"2393_CR42","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/acr.20268","volume":"62","author":"S van Koulil","year":"2010","unstructured":"van Koulil S, van Lankveld W, Kraaimaat FW, van Helmond T, Vedder A, van Hoorn H, Donders R, de Jong AJ, Haverman JF, Korff KJ, van Riel PL, Cats HA, Evers AW: Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia. Arthritis Care Res (Hoboken). 2010, 62: 1377-1385. 10.1002\/acr.20268.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"2393_CR43","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/ard.2010.148577","volume":"70","author":"S van Koulil","year":"2011","unstructured":"van Koulil S, van Lankveld W, Kraaimaat FW, van Helmond T, Vedder A, van Hoorn H, Donders AR, Wirken L, Cats H, van Riel PL, Evers AW: Tailored cognitive-behavioural therapy and exercise training improves the physical fitness of patients with fibromyalgia. Ann Rheum Dis. 2011, 70 (12): 2131-2133. 10.1136\/ard.2010.148577.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2393_CR44","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/art.24276","volume":"61","author":"W H\u00e4user","year":"2009","unstructured":"H\u00e4user W, Bernardy K, Arnold B, Offenb\u00e4cher M, Schiltenwolf M: Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum. 2009, 61 (2): 216-224. 10.1002\/art.24276.","journal-title":"Arthritis Rheum"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-15-450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-15-450\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-15-450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-15-450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T18:27:49Z","timestamp":1748456869000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-15-450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2393"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-15-450","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"23 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"450"}}